Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Immune Function

Research synthesisVery low evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 review studies, all reported beneficial but small effects of Lactobacillus brevis SBC8803 on immune function, including enhanced natural killer cell activity and increased secretory IgA levels. No statistically significant findings were reported, and study durations, doses, and forms were not consistently documented. The evidence base is limited to reviews, with no original clinical trials available for this specific strain-outcome pair.

  • Studied populations: patients with psoriasis (1 study)

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All three studies are literature reviews, not original clinical trials, limiting causal inference. Doses, durations, and forms were not reported in any study. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed).

Generated Jun 11, 2026
3 of 3 papers
Back to top